Getting To @CdogrunTo

Thank you, Minnesota! I am honored to be the Republican candidate for the U.S. Senate. Tonight’s results show Minnesotans are ready for a new direction. Together, we will bring common sense back to Washington, fight fraud, hold those responsible accountable, and win in November. Let’s get to work!

President Trump is hearing our calls to bring the Senate back! He’s considering a National Emergency to pass it! Keep speaking out! It’s working!

Sherri™ @FFT1776

14 hours ago

🚨Message to President Trump🚨 The Senate walked out on the SAVE America Act and election integrity. You have the constitutional power to CALL THEM BACK into session. Force this fight into the daylight and make every senator own where they stand. 🚨Call them back, Mr

154 1K 2K 68K 17

$RKLB Rocket Lab CFO Adam Spice: "We've seen large programs from Germany where the Bundeswehr announced a $40 billion constellation opportunity for people to have a chance to participate in it. And I think now we have a meaningful opportunity to go into programs like that and others in Europe in a more meaningful way."

Dave G @daveginvesting

16 hours ago

@peterrhague Well, Mynaric wasn't in the UK and that acquisition kickstarted this. But I do think Germany is also investing more in sovereign space.

3 0 28 10K 1

@WinnerInvestor Didn’t feel good at the time but it really was a smart move on their part.

Adrian Fontes is trying to duck out of debating me. And he’s doing it in the most pathetic and religiously insulting way possible. Adrian Fontes has requested a change in the debate date and made himself available on the one and only date that religious obligation would prevent me from debating him. September 21st is Yom Kippur, a religious holiday that is adhered to by Jewish residents of the State of Arizona including myself. Jews are forbidden from performing work of any kind on that day. Adrian Fontes already knows this, which is why the singular date he offered up was that date. This is cowardly, pathetic and un-American. Let me be very clear, I am more than happy to debate Mr. Fontes any other day and time and will clear my calendar. The simple truth is that Adrian is terrified of debating me because he knows I’ll expose his record of: ❌ Dismantling Arizona's proof of citizenship laws for voter registration ❌ Trying to stop cops from voting ❌ Attempting to seize the power to throw out votes from entire counties. ❌ Failing to protect your sensitive voter information Like I said, my calendar is clear. What's your excuse, Adrian?

There wouldn't be a housing shortage in America if 30 million illegals GTFO. There. I said it.

@SpaceInvestor_D Impressed with $RDW today. I think we go higher.

$RKLB after spending 25 days below the 200ema, we are now starting to close above it again. providing we continue to close above $77, we should begin to see a move up to $104 at the least, and possibly as high as $118 at the golden pocket, and this would be a very normal/simple retracement from the highs.

$RKLB I think some people missed the last paragraph here. The interstage did completed qualifications and the one for the first flight is being assembled

You are not bullish enough on $SOFI What a gift 🎁

Ashton Invests @Ashton_1nvests

13 hours ago

This chart is ridiculous. I could look at $SOFI member growth all day. Q1 2023: ~5.7M members Q2 2026: 15M+ members Quarter after quarter after quarter, the bars just keep getting taller. And the crazy part is the growth rate has barely slowed despite the member base getting

9 7 81 9K 3

$RKLB - Piper Sandler note this morning sums up the Rocket Lab thesis the best.... Alexander Potter Says that Rocket Lab’s “vertically-integrated approach will make it a long-term winner” “In the future, nobody will care if Neutron achieved its first launch in December 2026 or February 2027, but until there’s clarity on timing, we think investors can expect continued choppiness.”

SpacBobby @SpacBobby

15 hours ago

$RKLB - 🚨 BREAKING 🚨 *ROCKET LAB CEO PETER BECK SPEAKS ON BLOOMBERG TELEVISION *ROCKET LAB CEO: NEVER SEEN THE ROCKET INDUSTRY SO CONSTRAINED *ROCKET LAB: PUSHING TO GET FIRST NEUTRON LAUNCH DONE THIS YEAR

4 22 289 51K 14

$RKLB - Clear Street reiterates $129 PT on Rocket Lab and maintains buy rating We maintain our view that RKLB remains well positioned for accelerated growth through 2030E, driven by an industry-wide launch undersupply. At the same time, we recognize that near-term investors will overlook the strong top-line outlook and focus on: • Neutron "pad" and "launch" targets looks like a softening for 4Q window. • Revenue guide strong, cash flow disappoints on Neutron costs and transaction fees. Valuation: We continue to see the top-line growth momentum that underpins our long-term thesis, which calls for a 39% revenue CAGR out to 2030E. Despite this attractive growth profile, shares currently trade at only 20x and 15x our 2029E and 2030E revenue, respectively. We maintain a Buy rating and $129 PT, applying 26x to our unchanged 2030E revenue estimate of $3.1B.

$RKLB - Analyst Ratings After Q2 Earniings: KeyBanc: $135 PT - Overweight Stifel: $132 Pt - Buy Citizens: $130 PT - Market Outperform Cantor Fitzgerald: $96 -> $122 PT - Overweight Craig Hallum: $120 PT - Buy TD Cowen: $120 PT - Buy Roth Capital: $130 -> $110 PT - Buy Morgan Stanley: $105 PT - Overweight Baird: $100 PT - Outperform Piper Sandler: $83 PT - Neutral

To all the Supermarkets and big commercial stores that operate 'Self Check-outs'.... You are heading towards almost exclusively self-checkout now. Yesterday I went shopping at one such store and the lady checking receipts at the exit was stopping everyone. I didn't choose to participate in that nonsense, I had already filled my trolly, emptied my trolly and scanned the items, refilled my trolly, and so I just skipped the exit line and left. I heard her saying "Umm - Excuse me “ as I kept walking and raised the receipt above my head, leaving the store. You can either trust me to do self-checkout, or you can put your cashiers back in place like it used to be. • I'm not interested in proving that I did your job for you. • If you want me to be a cashier with no training then that's your problem not mine. • Keep employing young people and give them job opportunities. YOU DON'T PAY ME TO SCAN MY OWN SHOPPING. YOU DON’T GIVE ME STAFF DISCOUNT FOR WORKING FOR YOU. Signed… All of us Profits be for people… #Truth

BULLISH | ROCKET LAB! 🚀 🚀 RECORD REVENUE: $234 million, up 62% year-on-year. 🚀 RECORD BACKLOG: $2.36 billion, with $800+ million added post-quarter. 🚀 90+ LAUNCHES IN BACKLOG: The highest number in backlog in $RKLB history

The 10% sell off was an overreaction. Let’s go green. $RKLB

$RKLB: Stifel reiterated a Buy rating and $132.00 price target on Rocket Lab following the company’s second-quarter results. The aerospace company signed 26 new Electron/HASTE missions during the quarter and increased its total launch backlog to more than 90 missions. Overall backlog grew to approximately $2.4 billion, with an additional $800 million of bookings added after quarter-end. Space Systems revenue accelerated as SDA programs ramped up. Rocket Lab secured several defense awards during the period.

Stifel on $RKLB (Buy, PT $132): "Rocket Lab delivered a beat and raise, with 2Q’s results exceeding expectations on revenue, margins, and EBITDA. The company signed 26 new Electron/HASTE missions, increased total launch backlog to more than 90 missions, and grew overall backlog to approximately $2.4B, with an additional ~$800M of bookings added after quarter-end. Space Systems revenue accelerated sharply as SDA programs ramped, while Rocket Lab secured several notable defense awards that further strengthen its position as a diversified space prime contractor. Neutron remains on schedule for pad delivery in Q4:26, with management reporting multiple key hardware, engine, and integration milestones achieved during the quarter. Strategic initiatives continue to expand the company's long-term opportunity set, including the planned acquisition of Iridium, the introduction of the deployable GHOST launch system, and growing defense exposure. With accelerating growth, strong backlog visibility, and limited competition, Rocket Lab offers compelling long-term risk/reward despite near-term cash burn. Reiterate Buy." Analyst: Erik Rasmussen

🚨🚨 THE BIG MAMDANI CON IS EXPOSED 🚨🚨 Rudy Giuliani just EXPLODED. Democrats didn’t just win New York City. They stole it. A bombshell audit just uncovered 228,000 FRAUDULENT VOTES — more than enough to erase Zohran Mamdani’s entire 207,570-vote “victory.” Let that sink in. Out of the votes examined: • 7% came from nonexistent voter records • 6% used fake Social Security numbers • 10% belonged to people who don’t even live in New York • 1% had no Social Security number at all That’s nearly a quarter of a million phantom ballots. Giuliani didn’t hold back: “Do I think the Democratic Party cheated in this election? The answer is a RESOUNDING YES. They are the most crooked enterprise in the history of the United States.” This wasn’t an election. This was a heist. Zohran Mamdani is sitting in City Hall as an illegitimate mayor — installed by fraud, phantom voters, and the same dirty tricks we’ve seen before. The numbers don’t lie. The truth is out. And the establishment is already trying to bury it. Share this everywhere. Demand a real investigation. The people of New York — and America — deserve better than this con. #MamdaniCon #ElectionIntegrity #RudyGiuliani FOLLOW ME THE NEXT DROP WILL BE SHOCKING

The part I left out: Redwire's biotech arm Redwire has a drug company inside it called SpaceMD. It grows drug crystals in space. Here's why anyone pays for that. A lot of medicines are tiny solid crystals floating in liquid. When the crystals come out different sizes, the liquid goes thick, and you can't push it through a needle. Those drugs have to be given in hospital on a drip. Gravity is what makes the sizes uneven. Take gravity away and the crystals come out the same size, the liquid stays runny, and the patient can inject it at home instead. Redwire flies these experiments in a box called PIL-BOX. 54 have gone up since November 2023, growing 45 different drug crystals, including insulin and ones for cancer, obesity and diabetes. They don't make the drugs in space. They grow one tiny crystal up there, bring it home, and sell it to drug companies who copy it on Earth. Redwire gets a cut of every sale. Last week they signed their first commercial mission with SpaceX, flying up to 32 PIL-BOXes in 2028. None of this is in the numbers yet and the money is years away. Worth knowing it's there though.

Echo Analysis @EchoAnalysis

3 days ago

$RDW revenue was up 90% last quarter. They're now winning new orders 50% faster than they're delivering them. Fundamentals and technical breakdown 👇

26 20 288 59K 69